Acetylsalicylic acid Terminated Phase 3 Trials for Transcatheter Aortic Valve Replacement Prevention

IndicationsStatusPurposePhase
TerminatedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT02556203Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes